Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer

Breast Cancer Research and Treatment

Volumn 63, Issue 1, 2000, Pages 81-87

  Kang, Han Sung ^a   Youn, Yeo Kyu ^b   Oh, Seung Keun ^b   Choe, Kuk Jin ^b   Noh, Dong Young ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Breast cancer; Heterogeneity; Lymph nodes; Ploidy

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CELL CYCLE S PHASE; CLINICAL ARTICLE; DIPLOIDY; DISEASE ASSOCIATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RISK FACTORS; S PHASE;

EID: 0033794296     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006470614782     Document Type: Article

References (31)

1. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture
2. Tumor heterogeneity and the biology of cancer invasion and metastasis
3. Generation of phenotypic diversity and progression in metastatic tumor cells
4. Tumor heterogeneity
5. The cellular heterogeneity of malignant neoplasms: Implications for adjuvant chemotherapy
6. The biology of metastatic breast cancer
7. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants
8. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
9. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards
10. High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases
11. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization
12. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04
13. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
14. Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein
15. Cancer metastasis and angiogenesis: And imbalance of positive and negative regulation
16. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast
17. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
18. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma
19. Prognostic factors in recurrent breast cancer: Relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
20. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry
21. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer
22. Regional heterogeneity in breast carcinoma: Thymidine labeling index, steroid hormone receptors, DNA ploidy
23. DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy
24. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference
25. Pathologic correlates of prognosis in lymph node-positive breast carcinomas
26. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast
27. Prognostic significance of peritumoral vascular invasion in breast cancer
28. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer
29. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol
30. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IlIA breast cancer (> 10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy
31. Altered gene expression in drug-resistant human breast cancer cells